In this study, we assessed the impact of inherited variants in ABCB1, ABCG2, PXR, and CAR genes on dasatinib efficacy and toxicity in CML. The gene discussed is ABCB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.